Evidence map›Paper›PMID 35178475›Full record

ArticleOpen medicine (Warsaw, Poland)2022

Expression of DNM3 is associated with good outcome in colorectal cancer.

Shao-Ang Cheng, Xin Huang, Liang Jiang, Qi-Lian Liang, Xiao-Cui Hong, Hai-Xia Yang, Ke-Hui Hu, Xing-Bo Luo, Hui-Jie Zhang

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shao-Ang ChengOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Xin HuangOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Liang JiangInterventional Ward, Affiliated Hospital of Guangdong Medical University, 57 People Avenue Zhanjiang, 524001, China.
Qi-Lian LiangOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Xiao-Cui HongOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Hai-Xia YangOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Ke-Hui HuOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Xing-Bo LuoOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Hui-Jie ZhangOncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to reveal the potential value of dynamin3 (DNM3) in colorectal cancer (CRC) evaluation of clinical diagnosis and prognosis. A total of 100 tissue samples were collected from 50 patients with stages I-IV, CRC tissues (

Indexed as

clinicopathological characteristicscolorectal cancerdynamin3

Identifiers

PMID35178475
PMCPMC8812712
OpenAlexW4210361169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.